연구동향 분석

The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea

이승헌 유희경 김설희 고원중 김창기 박영길 김희진 2014년

논문상세정보
인용/피인용
' The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • drug resistance
  • mutation
  • mycobacteriumabscessusgroup
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,715 0

0.0%

' The Drug Resistance Profile of Mycobacterium abscessus Group Strains from Korea' 의 참고문헌

  • rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov
    Adékambi T Int J Syst Evol Microbiol 56 133-143 [2006]
  • gyrA and gyrB gene mutation in ciprofloxacin-resistant Mycobacterium massiliense clinical isolates from Southern Brazil
    Monego F Microb Drug Resist 18 1-6 [2012]
  • Stone MS. Spectrum of disease due to rapidly growing mycobacteria
    Wallace RJ Jr Rev Infect Dis 5 657-679 [1983]
  • Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans
    Ryoo SW J Clin Lab Anal 22 415-420 [2008]
  • Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases
    Han XY Am J Clin Pathol 128 612-621 [2007]
  • Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates
    Kim HY J Clin Microbiol 46 3384-3390 [2008]
  • Outcomes in patients with Mycobacterium abscessuss pulmonary disease treated with long-term injectable drugs
    Lyu J Respir Med 105 781-787 [2011]
  • Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene(erm)and clarithromycin susceptibility patterns
    Kim, H. Y. MICROBIOLOGY AND IMMUNOLOGY 54 347-353 [2010]
  • Molecular mechanisms of clarithromycin resistance in Mycobacterium avium: observation of multiple 23S rDNA mutations in a clonal population
    Meier A J Infect Dis 174 354-360 [1996]
  • Involvement of an efflux system in mediating high level of fluoroquinolone resistance in Mycobacterium smegmatis
    Banerjee SK Biochem Biophys Res Commun 226 362-368 [1996]
  • Involvement if cell impermeability in resistance to macrolides in some producer streptomycetes
    Fierro JF J Antibiot 41 142-144 [1988]
  • Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease
    Nash KA Antimicrob Agents Chemother 39 2625-2630 [1995]
  • Genetic basis for clarithromycin resistance among isolates of Mycobacterium chelonae and Mycobacterium abscessus
    Wallace RJ Jr Antimicrob Agents Chemother 40 1676-1681 [1996]
  • Genetic analysis of new 16S rRNA mutations conferring aminoglycoside resistance in Mycobacterium abscessus
    Nessar R J Antimicrob Chemother 66 1719-1724 [2011]
  • Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria
    Guillemin I Antimicrob Agents Chemother 42 2084-2088 [1998]
  • Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea
    Koh WJ Chest 129 341-348 [2006]
  • Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus
    Koh, W. J. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 183 3 405-410 [2011]
  • Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients
    Griffith, D. E. Am Rev Respir Dis 147 1271-1278 [1993]
  • Clinical and microbiologic outcomes in patients receiving treatment of Mycobacterium abscessus pulmonary disease
    Jarand J Clin Infect Dis 52 565-571 [2011]
  • Bacterial resistance mechanisms as therapeutic targets
    Coleman K J Antimicrob Chemother 33 1091-1116 [1994]
  • Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing
    Bastian S Antimicrob Agents Chemother 55 775-781 [2011]
  • Antibiotic treatment of Mycobacterium abscessus lung disease : A retrospective analysis of 65 patients
    Jeon, K. Am J Respir Crit Care Med 180 896-902 [2009]
  • An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial disease
    Griffith DE Am J Respir Crit Care Med 175 367-416 [2007]
  • Amoebal coculture of “Mycobacterium massiliense” sp. nov. from the sputum of a patient with hemoptoic pneumonia
    Adékambi T J Clin Microbiol 42 5493-5501 [2004]
  • A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae
    Prammananan T J Infect Dis 177 1573-1581 [1998]
  • A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae
    Nash, K. A. Antimicrob Agents Chemother 53 1367-1376 [2009]